INS and diabetes mellitus: Imatinib’s rapid diabetes-reversing effect is also difficult to be explained by its anti-apoptotic effect on β cells demonstrated by a previous study [8] because in diabetic NOD mice the residual β cells are not able to maintain euglycemia even if they are no longer undergoing apoptosis unless the ability of the residual β cells to secrete insulin is enhanced simultaneously.